Cell culture is the process by which eukaryotic or prokaryotic cells are grown outside their natural environment, under controlled laboratory conditions. It is one of the key tools used in molecular and cellular biology to study the physiology and biochemistry of cells (aging and metabolic studies), the effect of biomolecules and drugs on the cells, and carcinogenesis and mutagenesis studies. Cell culture has been identified as one of the fastest growing segments of the life sciences market.
The global cell culture market is undergoing significant transition in terms of product differentiation and new product launches in various market segments such as consumables and instruments. The cell culture market was valued at USD 6,097.0 million in 2013 and is projected to reach USD 11,314.5 million by 2022, expanding at a CAGR of 7.1% from 2014 to 2022. Increasing application areas of cell culture technology in cancer detection, drug discovery and manufacturing of biologics have triggered the growth of this market. In addition, utilization of cell culture in various applications such as developing model systems for research, studies of cellular structures and functions, stem cell research and genetic engineering. Furthermore, huge investment in research and development by life science companies, extensive academic and industry collaborations and innovation in stem cell research have also driven the global cell culture market. Use of cell and tissue culture as model systems for studying cellular mechanisms related to various diseases such as diabetes, Parkinson’s and Alzheimer’s, and evaluating drug response is one of the most promising applications of this technology.
Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=405
The cell culture market has been segmented into two major product types: consumables and instruments. Cell culture consumables have been further categorized into media, sera and reagents. Cell culture media is likely to be the fastest growing segment owing to increasing preference for animal-derived component free (ADCF) media due to ethical and quality concerns. The instruments segment includes culture systems, incubators, pipetting instruments, roller bottle equipment, biosafety cabinets, cryostorage equipment, and others. Technological innovations in the design and operation of cell culture instruments and rapid adoption of automated culture systems by researchers and manufacturers are the major factors driving the segment.
Based on geography, the cell culture market is segmented into North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). North America was recognized as the largest regional market globally in 2013. Ongoing robust research activities for the development of drugs and biologics and presence of major pharmaceutical, biotechnology and food and beverages companies in the region are some of the driving factors in this region. Europe held the second position in terms of revenue in 2013. Asia Pacific is expected to be the fastest growing cell culture market during the forecast period from 2014 to 2022, due to improving economic condition in countries such as India and China, and increasing number of contract manufacturing and contract research organizations in Asia Pacific. Japan, China, Australia, and India are the major markets in Asia Pacific that offer immense opportunities to the companies in the cell culture market. Continuous increase in health care expenditure in China and India are expected to play a key role in driving growth in these markets. The markets in Rest of the World (RoW) and Latin America would also grow significantly due to increasing public and private investment in life science researches, in particular cell culture. In addition, factors such as improving health care infrastructure, rising awareness, and flexible regulatory requirements in the region are driving the growth of the cell culture market.
Key players operating in the global cell culture market include Sigma-Aldrich Corporation, BD Biosciences, EMD Millipore, Thermo Fisher Scientific, Inc., GE Healthcare, Lonza Biosciences, VWR International, PromoCell GmbH and Corning Incorporated.